Sit Investment Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sit Investment Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,700	Closed	-$701K	–	540
2023 Q4	$701K	Hold	5,700	–	–	0.02%	387
2023 Q3	$738K	Hold	5,700	–	–	0.02%	364
2023 Q2	$707K	Hold	5,700	–	–	0.02%	384
2023 Q1	$834K	Hold	5,700	–	–	0.02%	366
2022 Q4	$908K	Hold	5,700	–	–	0.03%	359
2022 Q3	$760K	Hold	5,700	–	–	0.02%	357
2022 Q2	$889K	Hold	5,700	–	–	0.03%	339
2022 Q1	$887K	Hold	5,700	–	–	0.02%	362
2021 Q4	$726K	Hold	5,700	–	–	0.02%	390
2021 Q3	$742K	Hold	5,700	–	–	0.02%	378
2021 Q2	$1.01M	Hold	5,700	–	–	0.03%	361
2021 Q1	$937K	Hold	5,700	–	–	0.02%	363
2020 Q4	$941K	Hold	5,700	–	–	0.03%	359
2020 Q3	$813K	Hold	5,700	–	–	0.02%	357
2020 Q2	$629K	Hold	5,700	–	–	0.02%	365
2020 Q1	$569K	Hold	5,700	–	–	0.02%	366
2019 Q4	$851K	Hold	5,700	–	–	0.02%	360
2019 Q3	$730K	Hold	5,700	–	–	0.02%	356
2019 Q2	$813K	Hold	5,700	–	–	0.03%	360
2019 Q1	$815K	Hold	5,700	–	–	0.03%	360
2018 Q4	$707K	Hold	5,700	–	–	0.02%	361
2018 Q3	$958K	Hold	5,700	–	–	0.02%	340
2018 Q2	$982K	Hold	5,700	–	–	0.03%	358
2018 Q1	$861K	Hold	5,700	–	–	0.02%	366
2017 Q4	$768K	Sell	5,700 -2,200	-28%	-$305K	0.02%	393
2017 Q3	$1.16M	Hold	7,900	–	–	0.03%	341
2017 Q2	$1.23M	Hold	7,900	–	–	0.03%	331
2017 Q1	$1.15M	Hold	7,900	–	–	0.03%	340
2016 Q4	$861K	Sell	7,900 -1,700	-18%	-$189K	0.02%	348
2016 Q3	$1.17M	Hold	9,600	–	–	0.03%	292
2016 Q2	$1.36M	Hold	9,600	–	–	0.04%	279
2016 Q1	$1.25M	Hold	9,600	–	–	0.02%	295
2015 Q4	$1.35M	Hold	9,600	–	–	0.03%	289
2015 Q3	$1.27M	Hold	9,600	–	–	0.02%	294
2015 Q2	$1.69M	Hold	9,600	–	–	0.03%	262
2015 Q1	$1.66M	Sell	9,600 -700	-7%	-$120K	0.03%	262
2014 Q4	$1.69M	Hold	10,300	–	–	0.03%	281
2014 Q3	$1.65M	Hold	10,300	–	–	0.03%	287
2014 Q2	$1.51M	Hold	10,300	–	–	0.03%	310
2014 Q1	$1.43M	Buy	10,300 +1,800	+21%	+$271K	0.03%	320
2013 Q4	$1.08M	Buy	8,500 +4,100	+93%	+$424K	0.02%	346
2013 Q3	$405K	Buy	+4,400	New	+$355K	0.01%	387

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sit Investment Associates's JAZZ Position: Q1 2024 in Review

Sit Investment Associates sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 5,700 shares — an estimated $701K sold.

Sit Investment Associates first reported a position in JAZZ in Q3 2013 and held it in 42 quarters. The position peaked at $1.69M in Q2 2015. 480 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Sit Investment Associates reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Sit Investment Associates sold 5,700 Jazz Pharmaceuticals shares in Q1 2024, an estimated $701K.
Sit Investment Associates first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 42 quarters.
Sit Investment Associates's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2015.
480 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Sit Investment Associates's 13F filing for Q1 2024, filed 14 May 2024.